Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Why companies left AIM in November 2023

Growth: Keeping track of vessels on the seas

AIM new admission: Gas prospects in the UK Irish Sea Basin

Growth: Bundling payments

Aquis weekly movers: Western Selection returning cash

Income: Strong track record of payments

AIM weekly movers: Cautious optimism at WH Ireland

Income: Ready for a bounce back

AIM movers: Sondrel recovers and Panthera Resources cash outflow

Why companies left AIM in October 2023

Income: Royalty streams

AIM movers: Potential power project for Zanaga Iron Ore and Bens Creek reports higher loss

Income: Operational gearing set to push dividends higher

AIM movers: Horizonte Minerals secures interim finance and Tern investee company raises cash

Income: Double digit dividend growth

Income: Engineering rising dividends

Income: Underrated distribution potential

Bowen Fintech’s potential Japanese crowdfunding purchase

Income: Lettings fund dividend growth

Aquis weekly movers: Share price of new artificial intelligence flotation nearly trebles

Income: Building the dividend

AIM weekly movers: Helium One Global shares fall below placing price

AIM movers: Bidstack reaches €3m settlement and Bermuda authorities ask for review at R&Q Insurance

Tip update: Hargreaves Services increasing dividend despite German slowdown

AIM movers: tinyBuild secures cash and ex-dividends

AIM movers: Angus Energy financing and Versarien disposals delayed

Diversified Energy Company hit by political questions

AIM movers: Tertiary Minerals Zambian earn-in and Engage XR contracts delayed

Another cleantech spin-off from Molecular Energies

AIM movers: Eden Research gains approval in Italy and Cap-XX patent defeat

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020